<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://physiolgenomics.physiology.org">
<title>Physiological Genomics current issue</title>
<link>http://physiolgenomics.physiology.org</link>
<description>Physiological Genomics RSS feed -- current issue</description>
<prism:eIssn>1531-2267</prism:eIssn>
<prism:coverDisplayDate>Jul 15 2008 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Physiological Genomics</prism:publicationName>
<prism:issn>1094-8341</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/135?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/144?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/149?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/162?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/185?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/193?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/205?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/215?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://physiolgenomics.physiology.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://physiolgenomics.physiology.org/icons/banner/title.gif">
<title>Physiological Genomics</title>
<url>http://physiolgenomics.physiology.org/icons/banner/title.gif</url>
<link>http://physiolgenomics.physiology.org</link>
</image>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/135?rss=1">
<title><![CDATA[Genomic dissection of the cytokine-controlled STAT5 signaling network in liver]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/135?rss=1</link>
<description><![CDATA[
<P>Growth hormone (GH) controls the physiology and pathophysiology of the liver, and its signals are conducted by two members of the family of signal transducers and activators of transcription, STAT5A and STAT5B. Mice in which the <I>Stat5a/b</I> locus has been inactivated specifically in hepatocytes display GH resistance, the sex-specific expression of genes associated with liver metabolism and the cytochrome <I>P</I>-450 system is lost, and they develop hepatosteatosis. Several groups have shown by global gene expression profiling that a cadre of STAT5A/B target genes identify genetic cascades induced by GH and other cytokines. Evidence is accumulating that in the absence of STAT5A/B GH aberrantly activates STAT1 and STAT3 and their downstream target genes and thereby offers a partial explanation of some of the physiological alterations observed in <I>Stat5a/b</I>-null mice and human patients. We hypothesize that phenotypic changes observed in the absence of STAT5A/B are due to two distinct molecular consequences: first, the failure of STAT5A/B target genes to be activated by GH and second, the rerouting of GH signaling to other members of the STAT family. Rerouting of GH signaling to STAT1 and STAT3 might partially compensate for the loss of STAT5A/B, but it certainly activates biological programs distinct from STAT5A/B. Here we discuss the extent to which studies on global gene expression profiling have fostered a better understanding of the biology behind cytokine-STAT5A/B networks in hepatocytes. We also explore whether this wealth of information on gene activity can be used to further understand the roles of cytokines in liver disease.</P>
]]></description>
<dc:creator><![CDATA[Hosui, A., Hennighausen, L.]]></dc:creator>
<dc:date>2008-07-15</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00048.2008</dc:identifier>
<dc:title><![CDATA[Genomic dissection of the cytokine-controlled STAT5 signaling network in liver]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>143</prism:endingPage>
<prism:publicationDate>2008-07-15</prism:publicationDate>
<prism:startingPage>135</prism:startingPage>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/144?rss=1">
<title><![CDATA[The g.763G>C SNP of the bovine FASN gene affects its promoter activity via Sp-mediated regulation: implications for the bovine lactating mammary gland]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/144?rss=1</link>
<description><![CDATA[
<P>Fatty acid synthase (FASN) is an enzyme that catalyzes de novo synthesis of fatty acids in cells. The bovine <I>FASN</I> gene maps to BTA 19, where several quantitative trait loci for fat-related traits have been described. Our group recently reported the identification of a single nucleotide polymorphism (SNP), g.763G&gt;C, in the bovine <I>FASN</I> 5' flanking region that was significantly associated with milk fat content in dairy cattle. The g.763G&gt;C SNP was part of a GC-rich region that may constitute a <I>cis</I> element for members of the Sp transcription factor family. Thus the SNP could alter the transcription factor binding ability of the <I>FASN</I> promoter and consequently affect the promoter activity of the gene. However, the functional consequences of the SNP on <I>FASN</I> gene expression are unknown. The present study was therefore directed at elucidating the underlying molecular mechanism that could explain the association of the SNP with milk fat content. Three cellular lines (3T3L1, HepG2, and MCF-7) were used to test the promoter and the transcription factor binding activities by luciferase reporter assays and electrophoretic mobility shift assays, respectively. Band shift assays were also carried out with nuclear extracts from lactating mammary gland (LMG) to further investigate the role of the SNP in this tissue. Our results demonstrate that the SNP alters the bovine <I>FASN</I> promoter activity in vitro and the Sp1/Sp3 binding ability of the sequence. In bovine LMG, the specific binding of Sp3 may account for the association with milk fat content.</P>
]]></description>
<dc:creator><![CDATA[Ordovas, L., Roy, R., Pampin, S., Zaragoza, P., Osta, R., Rodriguez-Rey, J. C., Rodellar, C.]]></dc:creator>
<dc:date>2008-07-15</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00043.2008</dc:identifier>
<dc:title><![CDATA[The g.763G>C SNP of the bovine FASN gene affects its promoter activity via Sp-mediated regulation: implications for the bovine lactating mammary gland]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>148</prism:endingPage>
<prism:publicationDate>2008-07-15</prism:publicationDate>
<prism:startingPage>144</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/149?rss=1">
<title><![CDATA[Muscle unloading-induced metabolic remodeling is associated with acute alterations in PPAR{delta} and UCP-3 expression]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/149?rss=1</link>
<description><![CDATA[
<P>A number of physiological changes follow prolonged skeletal muscle unloading as occurs in spaceflight, bed rest, and hindlimb suspension (HLS) and also in aging. These include muscle atrophy, fiber type switching, and loss of the ability to switch between lipid and glucose usage, or metabolic inflexibility. The signaling and genomic events that precede these physiological manifestations have not been investigated in detail, particularly in regard to loss of metabolic flexibility. Here we used gene arrays to determine the effects of 24-h HLS on metabolic remodeling in mouse muscle. Acute unloading resulted in differential expression of a number of transcripts in soleus and gastrocnemius muscle, including many involved in lipid and glucose metabolism. These include the peroxisome proliferator-activated receptors (PPARs). In contrast to <I>Ppar</I>- and <I>Ppar</I>-, which were downregulated by acute HLS, <I>Ppar</I>- was upregulated concomitant with increased expression of its downstream target, uncoupling protein-3 (<I>Ucp-3</I>). However, differential expression of <I>Ppar</I>- was both acute and transient in nature, suggesting that regulation of PPAR may represent an adaptive, compensatory response aimed at regulating fuel utilization and maintaining metabolic flexibility.</P>
]]></description>
<dc:creator><![CDATA[Mazzatti, D. J., Smith, M. A., Oita, R. C., Lim, F.-L., White, A. J., Reid, M. B.]]></dc:creator>
<dc:date>2008-07-15</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00281.2007</dc:identifier>
<dc:title><![CDATA[Muscle unloading-induced metabolic remodeling is associated with acute alterations in PPAR{delta} and UCP-3 expression]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>161</prism:endingPage>
<prism:publicationDate>2008-07-15</prism:publicationDate>
<prism:startingPage>149</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/162?rss=1">
<title><![CDATA[Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/162?rss=1</link>
<description><![CDATA[
<P>This work represents a maiden effort to systematically screen the transcriptome of the healing wound-edge tissue temporally using high-density GeneChips. Changes during the acute inflammatory phase of murine excisional wounds were characterized histologically. Sets of genes that significantly changed in expression during healing could be segregated into the following five sets: up-early (6&ndash;24 h; cytokine-cytokine receptor interaction pathway), up-intermediary (12&ndash;96 h; leukocyte-endothelial interaction pathway), up-late (48&ndash;96 h; cell-cycle pathway), down-early (6&ndash;12 h; purine metabolism) and down-intermediary (12&ndash;96 h; oxidative phosphorylation pathway). Results from microarray and real-time PCR analyses were consistent. Results listing all genes that were significantly changed at any specific time point were further mined for cell-type (neutrophils, macrophages, endothelial, fibroblasts, and pluripotent stem cells) specificity. Candidate genes were also clustered on the basis of their functional annotation, linking them to inflammation, angiogenesis, reactive oxygen species (ROS), or extracellular matrix (ECM) categories. Rapid induction of genes encoding NADPH oxidase subunits and downregulation of catalase in response to wounding is consistent with the fact that low levels of endogenous H<SUB>2</SUB>O<SUB>2</SUB> is required for wound healing. Angiogenic genes, previously not connected to cutaneous wound healing, that were induced in the healing wound-edge included adiponectin, epiregulin, angiomotin, Nogo, and VEGF-B. This study provides a digested database that may serve as a valuable reference tool to develop novel hypotheses aiming to elucidate the biology of cutaneous wound healing comprehensively.</P>
]]></description>
<dc:creator><![CDATA[Roy, S., Khanna, S., Rink, C., Biswas, S., Sen, C. K.]]></dc:creator>
<dc:date>2008-07-15</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00045.2008</dc:identifier>
<dc:title><![CDATA[Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>184</prism:endingPage>
<prism:publicationDate>2008-07-15</prism:publicationDate>
<prism:startingPage>162</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/185?rss=1">
<title><![CDATA[Serial analysis of the vascular endothelial transcriptome under static and shear stress conditions]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/185?rss=1</link>
<description><![CDATA[
<P>We have utilized serial analysis of gene expression (SAGE) to analyze the response of human coronary artery endothelial cells (HCAECs) to laminar shear stress (LSS). Primary cultures of HCAECs were exposed to 15 dyn/cm<SUP>2</SUP> LSS for 24 h in a parallel plate flow chamber and compared with identical same passage cells cultured under static conditions. The expression levels of a number of functional categories of genes were reduced by shear stress including those encoding proteins involved in cell proliferation (CDC10, CDC20, CDC23, CCND1, CCNB1), angiogenesis (ANGPTL4, CTGF, CYR61, ENG, EPAS1, EGFR, LGALS3, PGK1, and SPARC), extracellular matrix and cell-matrix adhesion (EFEMP1, LOXL2, P4HB, FBN1, FN1, ITGA5, ITGAE, ITGAV, ILK, LAMR1) and ATP synthesis (ATP5G3, ATP5J2, ATP5L, ATP5D). We also observed an increase in the LSS-responsive expression of genes encoding stress response proteins, including HMOX1, which is significant since HMOX1 may have anti-inflammatory and vasodilatory vascular effects. The autosomal dominant polycystic kidney disease (ADPKD) genes PKD1 and PKD2 were also elevated by LSS. ADPKD is associated with vascular malfunction, including the impairment of vasoreactive processes. To our knowledge, this is the first SAGE-based analysis of the shear stress-responsive endothelial cell transcriptome. These immortal data provide a resource for further analyses of the molecular mechanisms underlying the biological response to LSS and contribute to the expanding collection of publicly available SAGE data.</P>
]]></description>
<dc:creator><![CDATA[Chu, T. J., Peters, D. G.]]></dc:creator>
<dc:date>2008-07-15</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.90201.2008</dc:identifier>
<dc:title><![CDATA[Serial analysis of the vascular endothelial transcriptome under static and shear stress conditions]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>192</prism:endingPage>
<prism:publicationDate>2008-07-15</prism:publicationDate>
<prism:startingPage>185</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/193?rss=1">
<title><![CDATA[Protocadherin 12 deficiency alters morphogenesis and transcriptional profile of the placenta]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/193?rss=1</link>
<description><![CDATA[
<P>Protocadherins are transmembrane proteins exhibiting homophilic adhesive activities through their extracellular domain. Protocadherin 12 (<I>Pcdh12</I>) is expressed in angiogenic endothelial cells, mesangial cells of kidney glomeruli, and glycogen cells of the mouse placenta. To get insight into the role of this protein in vivo, we analyzed PCDH12-deficient mice and investigated their placental phenotype. The mice were alive and fertile; however, placental and embryonic sizes were reduced compared with wild-type mice. We observed defects in placental layer segregation and a decreased vascularization of the labyrinth associated with a reduction in cell density in this layer. To understand the molecular events responsible for the phenotypic alterations observed in <I>Pcdh12</I><SUP>&ndash;/&ndash;</SUP> placentas, we analyzed the expression profile of embryonic day 12.5 mutant placentas compared with wild-type placentas, using pangenomic chips: 2,289 genes exhibited statistically significant changes in expressed levels due to loss of PCDH12. Functional grouping of modified genes was obtained by GoMiner software. Gene clusters that contained most of the differentially expressed genes were those involved in tissue morphogenesis and development, angiogenesis, cell-matrix adhesion and migration, immune response, and chromatin remodeling. Our data show that loss of PCDH12 leads to morphological alterations of the placenta and to notable changes in its gene expression profile. Specific genes emerging from the microarray screen support the biological modifications observed in PCDH12-deficient placentas.</P>
]]></description>
<dc:creator><![CDATA[Rampon, C., Bouillot, S., Climescu-Haulica, A., Prandini, M.-H., Cand, F., Vandenbrouck, Y., Huber, P.]]></dc:creator>
<dc:date>2008-07-15</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00220.2007</dc:identifier>
<dc:title><![CDATA[Protocadherin 12 deficiency alters morphogenesis and transcriptional profile of the placenta]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>204</prism:endingPage>
<prism:publicationDate>2008-07-15</prism:publicationDate>
<prism:startingPage>193</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/205?rss=1">
<title><![CDATA[Regulation of ZIP and ZnT zinc transporters in zebrafish gill: zinc repression of ZIP10 transcription by an intronic MRE cluster]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/205?rss=1</link>
<description><![CDATA[
<P>Resolving the mechanisms underlying the temporal and spatial profile of zinc transporter expression in response to zinc availability is key to understanding zinc homeostasis. The mRNA expression of seven zinc transporters was studied in zebrafish gills when treated with zinc deficiency/excess over a 14-day period. Of these, ZnT1, ZnT5, ZIP3, and ZIP10 were differentially expressed in response to changed zinc status. The mRNA level of zinc exporter, ZnT1, was upregulated in fish subjected to excess zinc and downregulated by zinc deprivation. This response was similar to that of metallothionein-2 (MT2). Zinc deficiency caused an increased abundance of mRNA for zinc importers ZnT5, ZIP3, and ZIP10. Expression of ZnT5 and ZIP10, but not ZIP3, was inhibited by excess zinc. Zinc influx function of ZIP10 was demonstrated by <SUP>65</SUP>Zn transport assays in <I>Xenopus</I> oocyte expression experiments, suggesting that the inverse relationship between zinc availability and ZIP10 expression serves to maintain zinc homeostasis. Two distinct transcription start sites (TSS) for ZIP10 were found in gill and kidney. Luciferase assays and mutation/deletion analysis of DNA fragments proximal to the respective TSS revealed that ZIP10 has two alternative promoters (P1 and P2) displaying opposite regulatory control in response to zinc status. Positive as well as negative regulation by zinc involves MRE clusters in the respective promoters. These results provide experimental evidence for MREs functioning as repressor elements, implicating MTF1 involvement in the negative regulation of ZIP10. This is in contrast to the well-established positive regulation by MTF1 of other genes, such as MT2 and ZnT1.</P>
]]></description>
<dc:creator><![CDATA[Zheng, D., Feeney, G. P., Kille, P., Hogstrand, C.]]></dc:creator>
<dc:date>2008-07-15</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.90206.2008</dc:identifier>
<dc:title><![CDATA[Regulation of ZIP and ZnT zinc transporters in zebrafish gill: zinc repression of ZIP10 transcription by an intronic MRE cluster]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>214</prism:endingPage>
<prism:publicationDate>2008-07-15</prism:publicationDate>
<prism:startingPage>205</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/215?rss=1">
<title><![CDATA[Localization of genetic loci controlling hydronephrosis in the Brown Norway rat and its association with hematuria]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/2/215?rss=1</link>
<description><![CDATA[
<P>The aim of this study was to investigate the genetic basis of congenital hydronephrosis (HN), a poorly defined pathological entity, with a rat model. The Brown Norway (BN) strain spontaneously presents a high incidence of apparently asymptomatic HN, whereas the LOU strain does not. A backcross was established between these two strains [BN <FONT FACE="arial,helvetica">x</FONT> (BN <FONT FACE="arial,helvetica">x</FONT> LOU)] and a genomewide scan was performed with 193 microsatellite markers on 121 males and 118 females of this population, which had been phenotyped and scored for HN severity (defined as degree of renal pelvic dilation), followed by linkage analysis with Mapmaker/QTL software. Bilateral HN score was significantly linked to a locus on chromosome 6 (<I>Z</I> scores 4.4 and 4.8 for all rats and for females, respectively). Suggestive loci were identified on chromosomes 2 (for only right-sided HN) and 4. This is the first study in rats to identify genetic loci for HN. Three candidate genes present in these loci were sequenced and insertions detected in <I>Id2</I> and <I>Agtr1b</I> genes in BN, which did not, however, lead to modified expression as measured by quantitative PCR. Production of a congenic line for part of the chromosome 6 locus confirmed its involvement in HN, but the phenotype was mild. Evidence of hematuria was observed in 9.6% of the backcross rats, mostly males and only in kidneys with HN, but not necessarily in the most severely affected. Hematuria also occurs in the BN colony used here, where it is due to papilloma-like lesions involving pelvic epithelial proliferation, but not in the LOU rat.</P>
]]></description>
<dc:creator><![CDATA[Kota, L., Schulz, H., Falak, S., Hubner, N., Osborne-Pellegrin, M.]]></dc:creator>
<dc:date>2008-07-15</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00221.2007</dc:identifier>
<dc:title><![CDATA[Localization of genetic loci controlling hydronephrosis in the Brown Norway rat and its association with hematuria]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>224</prism:endingPage>
<prism:publicationDate>2008-07-15</prism:publicationDate>
<prism:startingPage>215</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

</rdf:RDF>